Member Exclusive

Epigenetic targeting may provide new insight to personalized cancer treatment

A recent study led by researchers at the University of California, Merced (Merced, CA, USA) identified a gene and hormone combination that triggers prostate cancer, providing potential epigenetic drug targets for personalized medicine.

Go to the profile of Peter Brown
Apr 05, 2017
0
0

Please sign in or register for FREE

Register to EpigenomicsNet – the epigenetics and epigenomics network

EpigenomicsNet is a communal space where industry and academic professionals can come together to discuss the latest research and developments, share thoughts and opinions, and build valuable international relationships.

Register

No comments yet.